Amer First Mf Inv (ATAX) 5.65 $ATAX America First

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Amer First Mf Inv (ATAX) 5.65 $ATAX

America First Multifamily Investors, L.P. Announces the Sale of the Arboretum
GlobeNewswire - Wed Jul 13, 7:00AM CDT
America First Multifamily Investors, L.P. (NASDAQ:ATAX) announced today that on June 20, 2016 it sold the Arboretum, a senior citizen apartment property, held in its MF Property portfolio, located in Omaha, Nebraska for $30.2 million. ATAX will realize a gross gain of approximately $12.4 million, before direct and indirect expenses to be recognized, in the second quarter 2016.
ATAX: 5.65 (-0.01)

America First Multifamily Investors, L.P. Receives Proceeds of $13,869,000 From Issuance of Series A Preferred Units
GlobeNewswire - Thu May 19, 3:10PM CDT
On May 19, 2016, America First Multifamily Investors, L.P. (NASDAQ:ATAX) ("the Partnership" entered into a second Subscription Agreement to issue 1,386,900 Series A Preferred Units representing limited partnership interests in the Partnership (the "Series A Preferred Units" resulting in $13,869,000 in aggregate proceeds to the Partnership.
ATAX: 5.65 (-0.01)

America First Multifamily Investors, L.P. Announces the Retirement of Managers from the Board of Burlington Capital
GlobeNewswire - Fri May 06, 3:10PM CDT
On May 2, 2016, Clayton K. Yeutter, 85, and Martin A. Massengale, 82, voluntarily retired as members of the Board of Managers of Burlington Capital ("Burlington" or the "Company" , the general partner of the general partner of America First Multifamily Investors, L.P. ("ATAX" (NASDAQ:ATAX). Ambassador Yeutter and Dr. Massengale retired upon reaching the end of their previously agreed-upon term and their departure is not related to any disagreement with Burlington or ATAX regarding any financial, accounting, or other matters.
ATAX: 5.65 (-0.01)

America First Multifamily Investors, L.P. (Nasdaq: ATAX) to Ring The Nasdaq Stock Market Opening Bell
GlobeNewswire - Mon May 02, 9:00AM CDT
What:
NDAQ: 70.89 (-0.53), ATAX: 5.65 (-0.01)

America First posts 1Q profit
Automated Insights - Mon May 02, 7:55AM CDT
OMAHA, Neb. (AP) _ America First Multifamily Investors LP (ATAX) on Monday reported first-quarter profit of $2.5 million.
ATAX: 5.65 (-0.01)

America First Multifamily Investors, L.P. Reports First Quarter 2016 Earnings
GlobeNewswire - Mon May 02, 6:34AM CDT
On May 2, 2016, America First Multifamily Investors, L.P. (NASDAQ:ATAX) (the "Partnership" reported the following operating results:
ATAX: 5.65 (-0.01)

America First Multifamily Investors, L.P. To Ring the Nasdaq Stock Market Opening Bell and Host The First Quarter 2016 Webcast Earnings Presentation On Tuesday, May 3, 2016, at 10:30 a.m. Eastern Daylight Time
GlobeNewswire - Fri Apr 22, 7:05AM CDT
America First Multifamily Investors, L.P. (NASDAQ:ATAX) announces their visit, on May 3, 2016, to the Nasdaq MarketSite in Times Square to ring the Nasdaq Stock Market Opening Bell in celebration of its 30 anniversary as a Nasdaq listed company. In addition, ATAX will host the First Quarter 2016 webcast/earnings call for investors on Tuesday, May 3, 2016, at 10:30 a.m. Eastern Daylight Time to discuss ATAX's First Quarter 2016 results.
ATAX: 5.65 (-0.01)

America First Multifamily Investors, L.P. Issues $10 Million Series A Preferred Units
GlobeNewswire - Thu Mar 31, 7:15AM CDT
On March 30, 2016, America First Multifamily Investors, L.P. (NASDAQ:ATAX) ("the Partnership" entered into a Subscription Agreement to issue Series A Preferred Units representing limited partnership interests in the Partnership (the "Series A Preferred Units" resulting in $10,000,000 in aggregate proceeds to the Partnership.
ATAX: 5.65 (-0.01)

America First Multifamily Investors, L.P. Announces the Sale of Its Two Remaining Consolidated Variable Interest Entities
GlobeNewswire - Wed Jan 20, 7:12AM CST
America First Multifamily Investors, L.P. (NASDAQ:ATAX) announces the fourth quarter of 2015 sales of Bent Tree and Fairmont Oaks, the two remaining properties reported by ATAX as Consolidated Variable Interest Entities ("Consolidated VIE's" .
ATAX: 5.65 (-0.01)

Active Equities to Watch in the Financial Sector - Western Asset Mortgage Capital, OFG Bancorp., Arlington Asset Investment, and America First Multifamily Investors
ACCESSWIRE - Wed Jan 06, 7:05AM CST
NEW YORK, NY / ACCESSWIRE / January 6, 2016 / Park Lane Advisor has initiated coverage on the following equities: Western Asset Mortgage Capital Corporation (NYSE: WMC), OFG Bancorp (NYSE: OFG), Arlington Asset Investment Corporation (NYSE: AI), and America First Multifamily Investors L.P. (NASDAQ: ATAX). Free research report on Western Asset Mortgage Capital can be accessed at http://www.parklaneadvisor.com/ On Tuesday, January 05, 2016, the NASDAQ Composite ended at 4,891.43, down 0.24%, the Dow Jones Industrial Average edged 0.06% higher, to finish the day at 17,158.66, and the S&P 500 closed at 2,016.71, up 0.20%. The gains were broad based as six out of nine sectors ended the session in positive. Register for your complimentary reports at the links given below.
OFG: 10.61 (+0.02), AI: 14.18 (-0.01), WMC: 9.92 (+0.03), ATAX: 5.65 (-0.01)

America First Multifamily Investors, L.P. Schedules Third Quarter 2015 Conference Call for Thursday, November 12th at 4:30 p.m. Eastern
GlobeNewswire - Tue Nov 03, 3:10PM CST
America First Multifamily Investors, L.P. (NASDAQ:ATAX) announced today that it will host a conference call for investors on Thursday, November 12 at 4:30 p.m. ET to discuss the Company's Third Quarter 2015 results.
ATAX: 5.65 (-0.01)

New Strong Buy Stocks for October 12th
Zacks Equity Research - Zacks Investment Research - Mon Oct 12, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
BERY: 41.27 (+0.28), AAC: 21.81 (+0.31), AMGN: 174.25 (+0.09), ATRS: 1.05 (+0.02), ATAX: 5.65 (-0.01)

Bill Gross Indicts PIMCO, Accuses Colleagues of Conspiracy
Zacks Equity Research - Zacks Investment Research - Fri Oct 09, 10:30AM CDT
On Thursday, Gross filed a lawsuit against PIMCO, the company he co-founded, alleging that several of his former colleagues conspired to oust him in order to boost their own careers and have larger claim in his annual bonus
MRCC: 15.22 (+0.04), JNS: 14.83 (-0.10), ATAX: 5.65 (-0.01)

BlackRock Recommends Revised Rules Post August Rout
Zacks Equity Research - Zacks Investment Research - Thu Oct 08, 3:45PM CDT
BlackRock published a paper on Wednesday that outlines "doable" recommendations to avoid another massacre similar to the rout witnessed on Aug 24, 2015.
MRCC: 15.22 (+0.04), STT: 66.29 (+0.35), BLK: 367.20 (-1.12), ATAX: 5.65 (-0.01)

What Makes Och-Ziff Capital Management (OZM) a Strong Sell?
Zacks Equity Research - Zacks Investment Research - Thu Oct 08, 7:40AM CDT
Och-Ziff Capital Management (OZM) has witnessed a significant price decline in the past one month, and it has lately seen negative earnings estimate revisions as well.
OZM: 3.80 (+0.45), ATAX: 5.65 (-0.01)

Noah Holdings Limited (NOAH) Looks Good: Stock Jumps 5.5%
Zacks Equity Research - Zacks Investment Research - Thu Oct 08, 7:35AM CDT
Noah Holdings Limited (NOAH) was a big mover last session, as the company saw its shares rise over 5% on the day.
NOAH: 25.88 (+0.13), ATAX: 5.65 (-0.01)

Oaktree (OAK) in Focus: Stock Falls 5.1%
Zacks Equity Research - Zacks Investment Research - Fri Oct 02, 7:35AM CDT
Oaktree Capital saw a big move last session as the company's shares fell by over 5% on the day
OAK: 45.19 (-0.17), ATAX: 5.65 (-0.01)

Why Should You Drop BlackRock from Your Portfolio Now?
Zacks Equity Research - Zacks Investment Research - Tue Sep 29, 2:20PM CDT
Though BlackRock enjoys diversified revenue stream, increased dependence on a particular type of fees that could be adversely influenced by market fluctuations and foreign exchange translations is expected to hurt profitability.
MRCC: 15.22 (+0.04), SAMG: 12.09 (+0.03), BLK: 367.20 (-1.12), ATAX: 5.65 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Peptide Tracker Refresh Unveils New Planning Features

Updated Category News Views 50

Peptide Tracker's Latest Updates: A Game Changer? I'll tell you what—if you're keeping tabs on your peptide intake like a seasoned gardener checks the soil, Peptide Tracker's fresh versions 3.2.0 and 3.3.0 might just be your new best mates. With the addition of washout scheduling and a robust six-month schedule preview, this isn't just another fancy tech update. It's...

Continue Reading
Univers Partners to Propel Physical AI Across Industries

Updated Category News Views 145

Univers Sets Sights on Global Physical AI Expansion Now here's a tune we've been humming for a while—AI is coming to take over the mundane, and Univers seems to think it's got the right band together to make that a full-blown concert in the built environment. Announced right in the heart of Antalya, Türkiye, at the esteemed COP31, we're seeing Univers grab hands with...

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 25

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 159

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
MatterSeek Platform Revolutionizing Materials R&D Worldwide

Updated Category News Views 83

Innovating the R&D Landscape with MatterSeek In the ever-changing realm of materials research and development, Yuyao Technology's latest innovation, MatterSeek, is a game changer. It's a slick launch, folks, redefining how we look at the R&D landscape through its AI-driven abilities. This ain't just another pie-in-the-sky platform; it's an actual workhorse designed to...

Continue Reading
TOYO Slips on Earnings Amid Strategic Expansion

Updated Category News Views 155

TOYO's Solar Journey: Ups and Downs If there's one thing riding high on volatility these days, it's solar energy. TOYO Co., Ltd. (Nasdaq: TOYO) spilled the beans on Q3 2026, and oh boy, it's a mixed bag. Revenue Jumps, Yet Profitability Takes a Hit Let's cut to the chase: the third quarter served up a 4.8% dip in revenue year-over-year, landing at $129 million, though it...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 10

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 19

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 101

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 104

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading

Top 5 Most Recently Viewed Articles

Unlocking Solutions: The N-SISS Fellowship for Innovators

Updated Category News Views 146

Applications Open for the N-SISS Fellowship Innovative research incubator focused on eliminating negative health outcomes Are you a doctoral-level nurse scientist or engaged in related fields like public health and social sciences? The Institute for Policy Solutions (IPS) is thrilled to announce the opening of applications for the next cohort of the Nursing Science...

Continue Reading
Jump Global Media Expands Portfolio with Major Acquisition

Updated Category News Views 694

Jump Global Media's Strategic Acquisition Jump Global Media Group UK Ltd. (Jump GMG), a leading multi-platform entertainment company, has made a significant move in the film and television industry by acquiring the rights to The Empress and I, a compelling memoir penned by renowned author Donna Stein. The Story Behind the Memoir The Empress and I narrates an extraordinary...

Continue Reading
VIVO Agency Welcomes Jennifer Mugnaini as New EVP of Services

Updated Category News Views 126

VIVO Agency Appoints Jennifer Mugnaini as EVP of Client Services Strategically enhancing client leadership and driving growth, VIVO Agency has named Jennifer Mugnaini as the new Executive Vice President of Client Services. With more than twenty years of extensive experience in healthcare and MedTech marketing, Jen is poised to elevate the agency's client service teams,...

Continue Reading
IMU Biosciences Welcomes Dr. Carlos Paya to Its Board

Updated Category News Views 197

IMU Biosciences Welcomes Dr. Carlos Paya as Non-Executive Director IMU Biosciences, a pioneering biotechnology company focused on innovating how the immune system is understood and treated, has recently bolstered its leadership team. The company is thrilled to announce the appointment of Dr. Carlos Paya as a Non-Executive Director. His extensive experience in both...

Continue Reading
Significant Impact of Older Voters in Pittsburgh's Future

Updated Category News Views 225

Older Voters in Pittsburgh: A Key Factor in the Upcoming Election In the vibrant city of Pittsburgh, voters aged 50 and older are gearing up to play a crucial role in the next mayoral election. Recent insights reveal that this demographic not only makes up a substantial percentage of the voting public, but they are also highly engaged on critical issues that impact their...

Continue Reading